Literature DB >> 30825913

Concomitant intrauterine growth restriction alters the lipoprotein profile in preeclampsia.

Christine Contini1, B Sophia Winkler2, Nicolai Maass3, Ibrahim Alkatout4, Karl Winkler5, Ulrich Pecks6.   

Abstract

OBJECTIVE: Preeclampsia and intrauterine growth restriction (IUGR) are related conditions. We aimed to characterise common lipid changes.
METHODS: Triglyceride and cholesterol levels of patients 24-42 weeks of gestation with IUGR (n = 52), hypertensive IUGR (HIUGR, n = 28), and preeclampsia without IUGR (PE, n = 56) were compared to a control group (CTRL, n = 167). In addition, 60 sera (n = 10 of each pathology IUGR, HIUGR, PE (without IUGR) compared to n = 30 matched CTRL) of severe early onset cases <34 weeks of gestation were chosen and further analysed by ultracentrifugation lipid subfractionation including VLDL, IDL, LDL, and HDL composition.
RESULTS: In the full cohort we found low cholesterol in IUGR (p = 0.0405), while triglyceride levels were high in PE (p < 0.0001). Lipid concentrations in HIUGR did not differ significantly from CTRL. In the 60 patients analysed by lipid subfractionation, triglyceride levels were increased in the VLDL subfraction in PE (p < 0.01), however, LDL-bound ApoB and cholesterol levels were lower in IUGR and HIUGR (p < 0.0001 for total cholesterol and p < 0.001 for ApoB in both groups), but not in PE when compared to CTRL.
CONCLUSION: Low cholesterol, especially LDL cholesterol levels are a feature of IUGR while high triglyceride levels are a feature of preeclampsia. Increased VLDL-triglycerides suggest a disturbed conversion to LDL in preeclampsia. Of note, the presence of IUGR in hypertensive disorders further alters lipid profiles, which may explain heterogeneous data on lipid values for preeclampsia in the literature. Study groups have to be selected carefully to avoid misinterpretation.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  IUGR; LDL-cholesterol; Lipid metabolism; Preeclampsia; Triglycerides

Mesh:

Substances:

Year:  2018        PMID: 30825913     DOI: 10.1016/j.preghy.2018.12.006

Source DB:  PubMed          Journal:  Pregnancy Hypertens        ISSN: 2210-7789            Impact factor:   2.899


  3 in total

1.  Resistin Modulates Low-Density Lipoprotein Cholesterol Uptake in Human Placental Explants via PCSK9.

Authors:  Sonia Nava-Salazar; Arturo Flores-Pliego; Giovanni Pérez-Martínez; Sandra Parra-Hernández; America Vanoye-Carlo; Francisco Ibarguengoitia-Ochoa; Otilia Perichart-Perera; Enrique Reyes-Muñoz; Juan Mario Solis-Paredes; Salvador Espino Y Sosa; Guadalupe Estrada-Gutierrez
Journal:  Reprod Sci       Date:  2022-04-25       Impact factor: 3.060

2.  Simultaneous use of Tumor Necrosis Factor, Lipid Profile, and β-hCG As Markers of Severity of Preeclampsia.

Authors:  Reham Elazab; Mostafa Alkhiary; Mohamed Bedairi; Alaa Wageh
Journal:  J Obstet Gynaecol India       Date:  2021-09-24

3.  Metabolic reprogramming by Zika virus provokes inflammation in human placenta.

Authors:  Qian Chen; Jordi Gouilly; Yann J Ferrat; Ana Espino; Quentin Glaziou; Géraldine Cartron; Hicham El Costa; Reem Al-Daccak; Nabila Jabrane-Ferrat
Journal:  Nat Commun       Date:  2020-06-11       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.